Growth Metrics

Tandem Diabetes Care (TNDM) Cash & Equivalents Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.15%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 24.05%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -7.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 100.41%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -22.13%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 20.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 23.57%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -7.71%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 156.03%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 234.72%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 234.72%
Dec 31, 2025 30.91%
Sep 30, 2025 87.50%
Jun 30, 2025 34.42%
Mar 31, 2025 -9.16%
Dec 31, 2024 17.61%
Sep 30, 2024 -38.40%
Jun 30, 2024 -63.52%
Mar 31, 2024 -53.84%
Dec 31, 2023 -65.88%
Sep 30, 2023 -35.69%
Jun 30, 2023 13.73%
Mar 31, 2023 36.38%
Dec 31, 2022 142.36%
Sep 30, 2022 10.15%
Jun 30, 2022 16.62%
Mar 31, 2022 -22.44%
Dec 31, 2021 -24.77%
Sep 30, 2021 -13.21%
Jun 30, 2021 -55.69%
Mar 31, 2021 62.17%
Dec 31, 2020 84.88%
Sep 30, 2020 181.11%
Jun 30, 2020 483.06%
Mar 31, 2020 84.16%
Dec 31, 2019 22.35%
Sep 30, 2019 -59.45%
Jun 30, 2019 -24.51%
Mar 31, 2019 -35.37%
Dec 31, 2018 205.30%
Sep 30, 2018 568.79%
Jun 30, 2018 84.81%
Mar 31, 2018 102.64%
Dec 31, 2017 585.00%
Sep 30, 2017 -5.40%
Jun 30, 2017 -9.58%
Mar 31, 2017 -23.95%
Dec 31, 2016 -95.36%
Sep 30, 2016 -58.44%
Jun 30, 2016 -34.13%
Mar 31, 2016 -35.07%
Dec 31, 2015 38.21%
Sep 30, 2015 21.51%
Jun 30, 2015 -28.48%
Mar 31, 2015 -18.58%
Dec 31, 2014 -74.94%
Sep 30, 2014 128.67%
Jun 30, 2014 113.08%
Mar 31, 2014 160.98%